Glutaminase activity determines cytotoxicity of l-asparaginases on most leukemia cell lines
Tóm tắt
Từ khóa
Tài liệu tham khảo
Avramis, 2006, Asparaginase (native ASNase or pegylated ASNase) in the treatment of acute lymphoblastic leukemia, Int J Nanomed, 1, 241
Pieters, 2011, l-Asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase, Cancer, 117, 238, 10.1002/cncr.25489
Asselin, 1993, Comparative pharmacokinetic studies of three asparaginase preparations, J Clin Oncol, 11, 1780, 10.1200/JCO.1993.11.9.1780
Oettgen, 1967, Inhibition of leukemias in man by l-asparaginase, Cancer Res, 27, 2619
Aslanian, 2001, Multiple adaptive mechanisms affect asparagine synthetase substrate availability in asparaginase-resistant MOLT-4 human leukaemia cells, Biochem J, 358, 59, 10.1042/bj3580059
Ding, 2005, Epigenetic changes in the repression and induction of asparagine synthetase in human leukemic cell lines, Leukemia, 19, 420, 10.1038/sj.leu.2403639
Fine, 2005, A genome-wide view of the in vitro response to l-asparaginase in acute lymphoblastic leukemia, Cancer Res, 65, 291, 10.1158/0008-5472.291.65.1
Abbatiello, 2008, Mass spectrometric quantification of asparagine synthetase in circulating leukemia cells from acute lymphoblastic leukemia patients, J Proteomics, 71, 61, 10.1016/j.jprot.2007.11.009
Balasubramanian, 2013, Asparagine synthetase: regulation by cell stress and involvement in tumor biology, Am J Physiol Endocrinol Metab, 304, E789, 10.1152/ajpendo.00015.2013
Hermanova, 2012, Low expression of asparagine synthetase in lymphoid blasts precludes its role in sensitivity to l-asparaginase, Exp Hematol, 40, 657, 10.1016/j.exphem.2012.04.005
Su, 2008, Correlation between asparaginase sensitivity and asparagine synthetase protein content, but not mRNA, in acute lymphoblastic leukemia cell lines, Pediatr Blood Cancer, 50, 274, 10.1002/pbc.21213
Dimitriou, 2014, Expression levels of ASNS in mesenchymal stromal cells in childhood acute lymphoblastic leukemia, Int J Hematol, 99, 305, 10.1007/s12185-014-1509-y
Appel, 2006, Up-regulation of asparagine synthetase expression is not linked to the clinical response l-asparaginase in pediatric acute lymphoblastic leukemia, Blood, 107, 4244, 10.1182/blood-2005-06-2597
Kitoh, 1990, Metabolic basis for differential glutamine requirements of human leukemia cell lines, J Cell Physiol, 143, 150, 10.1002/jcp.1041430120
Le, 2012, Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells, Cell Metab, 15, 110, 10.1016/j.cmet.2011.12.009
Newsholme, 2001, Why is l-glutamine metabolism important to cells of the immune system in health, postinjury, surgery or infection?, J Nutr, 131, 2515S, 10.1093/jn/131.9.2515S
Richards, 2006, Asparagine synthetase chemotherapy, Annu Rev Biochem, 75, 629, 10.1146/annurev.biochem.75.103004.142520
Willems, 2013, Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia, Blood, 122, 3521, 10.1182/blood-2013-03-493163
Samudio, 2013, Asparaginase unveils glutamine-addicted AML, Blood, 122, 3398, 10.1182/blood-2013-09-526392
Avramis, 2005, Pharmacokinetic/pharmacodynamic relationships of asparaginase formulations: the past, the present and recommendations for the future, Clin Pharmacokinet, 44, 367, 10.2165/00003088-200544040-00003
Covini, 2012, Expanding targets for a metabolic therapy of cancer: l-asparaginase, Recent Patents Anticancer Drug Discov, 7, 4, 10.2174/157489212798358001
Avramis, 2012, Asparaginases: biochemical pharmacology and modes of drug resistance, Anticancer Res, 32, 2423
Reinert, 2006, Role of glutamine depletion in directing tissue-specific nutrient stress responses to l-asparaginase, J Biol Chem, 281, 31222, 10.1074/jbc.M604511200
Chan, 2014, The glutaminase activity of l-asparaginase is not required for anticancer activity against ASNS-negative cells, Blood, 123, 3596, 10.1182/blood-2013-10-535112
Ehsanipour, 2013, Adipocytes cause leukemia cell resistance to l-asparaginase via release of glutamine, Cancer Res, 73, 2998, 10.1158/0008-5472.CAN-12-4402
Fei, 2010, Activity of the Aurora kinase inhibitor VX-680 against Bcr/Abl-positive acute lymphoblastic leukemias, Mol Cancer Ther, 9, 1318, 10.1158/1535-7163.MCT-10-0069
Cappelletti, 2008, Helicobacter pylori l-asparaginase: a promising chemotherapeutic agent, Biochem Biophys Res Commun, 377, 1222, 10.1016/j.bbrc.2008.10.118
Maggi, 2015, Engineering of Helicobacter pylori l-asparaginase: characterization of two functionally distinct groups of mutants, PLOS ONE, 10, e0117025, 10.1371/journal.pone.0117025
Distasio, 1976, Purification and characterization of l-asparaginase with anti-lymphoma activity from Vibrio succinogenes, J Biol Chem, 251, 6929, 10.1016/S0021-9258(17)32924-1
Warrell, 1982, Clinical evaluation of succinylated Acinetobacter glutaminase-asparaginase in adult leukemia, Cancer Treat Rep, 66, 1479
Mok, 2011, Glutamine supplementation in sick children: is it beneficial?, J Nutr Metab, 2011, 10.1155/2011/617597
Wise, 2010, Glutamine addiction: a new therapeutic target in cancer, Trends Biochem Sci, 35, 427, 10.1016/j.tibs.2010.05.003
Purwaha, 2014, Targeted metabolomic analysis of amino acid response to l-asparaginase in adherent cells, Metabolomics, 1
Iwamoto, 2007, Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase, J Clin Invest, 117, 1049, 10.1172/JCI30235
Offman, 2011, Rational engineering of l-asparaginase reveals importance of dual activity for cancer cell toxicity, Blood, 117, 1614, 10.1182/blood-2010-07-298422